NCT02094703View on ClinicalTrials.gov

The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females

PHASE4UnknownINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
Urinary Tract Infection
Interventions
DRUG

Levofloxacin

DRUG

Solifenacin succinate

DRUG

Placebo (for Solifenacin succinate)

Trial Locations (1)

10430

RECRUITING

Cipto Mangunkusumo Hospital, Jakarta

Sponsors

Collaborators (1)

Pharos Life Corporation
All Listed Sponsors
collaborator

Astellas Pharma Indonesia Inc.

INDUSTRY

collaborator

Pharos Life Corporation

INDUSTRY

lead

Dr Cipto Mangunkusumo General Hospital

OTHER

NCT02094703 - The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females | Biotech Hunter | Biotech Hunter